About Flow Pharma
Flow Pharma is a private company based in Warrensville Heights, Ohio. It has reported $3,814,710 raised in four offerings on Form D since February 2018. Its chief executive is Reid Rubsamen.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 31, 2024 | Aug 1, 2024amended Aug 8, 2024 | $225,000of $40.0M target | 3 | $75,000 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 20, 2022 | Nov 2, 2022 | $180,000of $10.5M target | 8 | $22,500 | EquityRule 506(c) | Form D ↗ |
| Mar 21, 2016 | Feb 28, 2018 | $2,260,000target not set | 42 | $53,810 | Debt, Convertible DebtRule 506(b) | Form D ↗ |
| Apr 29, 2011 | Feb 28, 2018 | $1,149,710target not set | 17 | $67,630 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $3,814,710 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Flow Pharma's Form D filed Aug 8, 2024.
Earlier filings also listed Tom Brady (executive officer, last listed Nov 2022), Thomas Barnish (executive officer, last listed Nov 2022), Stephen Farr (director, last listed Nov 2022), Gil Van Bokkelen (executive officer, last listed Nov 2022), Charles Herst (executive officer, last listed Nov 2022) and Lester Lloyd (executive officer and director, last listed Feb 2018).